IL17A and neoplasm: Inhibited tumor growth.Enhanced tumor immune response.Increased the number of tumor-infiltrating M1 macrophages and dendritic cells.Enhanced the secretion of IL17A in spleen.Increased the level of TNF-α in tumor.